Urokinase plasminogen activator receptor: A functional integrator of extracellular proteolysis, cell adhesion, and signal transduction

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 4, 2013, Pages 347-355

  Ferraris, Gianmaria Sarra ^a   Sidenius, Nicolai ^a  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

adhesion; proteolysis; signaling; uPAR; vitronectin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE P38; TYROSINE KINASE RECEPTOR; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CRYSTAL STRUCTURE; EXTRACELLULAR MATRIX; HUMAN; HYDROLYSIS; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; HUMANS; PROTEOLYSIS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SIGNAL TRANSDUCTION;

EID: 84878280950     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1334485     Document Type: Article

References (79)

1. Andronicos N. M., Chen E. I., Baik N., et al. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood: 2010; 115 7 1319 1330
2. Ellis V., Behrendt N., Dano K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem: 1991; 266 19 12752 12758 (Pubitemid 21907159)
3. Bugge T. H., Kombrinck K. W., Flick M. J., Daugherty C. C., Danton M. J., Degen J. L. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell: 1996; 87 4 709 719 (Pubitemid 26386944)
4. Carmeliet P., Moons L., Lijnen R., et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet: 1997; 17 4 439 444 (Pubitemid 27518393)
5. Estreicher A., Mühlhauser J., Carpentier J. L., Orci L., Vassalli J. D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol: 1990; 111 2 783 792
6. Connolly B. M., Choi E. Y., Gårdsvoll H., et al. Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation. Blood: 2010; 116 9 1593 1603
7. Cubellis M. V., Wun T. C., Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J: 1990; 9 4 1079 1085
8. Nykjaer A., Conese M., Christensen E. I., et al. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J: 1997; 16 10 2610 2620 (Pubitemid 27226200)
9. Hayman E. G., Pierschbacher M. D., Ohgren Y., Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A: 1983; 80 13 4003 4007 (Pubitemid 13072774)
10. Seiffert D., Loskutoff D. J. Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J Biol Chem: 1991; 266 5 2824 2830 (Pubitemid 21909141)
11. Deng G., Curriden S. A., Wang S., Rosenberg S., Loskutoff D. J. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol: 1996; 134 6 1563 1571 (Pubitemid 26318027)
12. Moser T. L., Enghild J. J., Pizzo S. V., Stack M. S. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Biochem J: 1995; 307 Pt 3 867 873
13. Preissner K. T. Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator. Biochem Biophys Res Commun: 1990; 168 3 966 971 (Pubitemid 20175974)
14. Zheng X., Saunders T. L., Camper S. A., Samuelson L. C., Ginsburg D. Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci U S A: 1995; 92 26 12426 12430 (Pubitemid 26014082)
15. Dewerchin M., Nuffelen A. V., Wallays G., et al. Generation and characterization of urokinase receptor-deficient mice. J Clin Invest: 1996; 97 3 870 878 (Pubitemid 26057107)
16. Waltz D. A., Sailor L. Z., Chapman H. A. Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest: 1993; 91 4 1541 1552 (Pubitemid 23127356)
17. Waltz D. A., Chapman H. A. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem: 1994; 269 20 14746 14750 (Pubitemid 24194041)
18. Wei Y., Waltz D. A., Rao N., Drummond R. J., Rosenberg S., Chapman H. A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem: 1994; 269 51 32380 32388
19. Sidenius N., Andolfo A., Fesce R., Blasi F. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization. J Biol Chem: 2002; 277 31 27982 27990 (Pubitemid 34966747)
20. Gårdsvoll H., Ploug M. Mapping of the vitronectin-binding site on the urokinase receptor: involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region. J Biol Chem: 2007; 282 18 13561 13572 (Pubitemid 47100512)
21. Xu X., Gårdsvoll H., Yuan C., Lin L., Ploug M., Huang M. Crystal structure of the urokinase receptor in a ligand-free form. J Mol Biol: 2012; 416 5 629 641
22. Mertens H. D., Kjaergaard M., Mysling S., et al. A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR). J Biol Chem: 2012; 287 41 34304 34315
23. Cunningham O., Andolfo A., Santovito M. L., Iuzzolino L., Blasi F., Sidenius N. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J: 2003; 22 22 5994 6003 (Pubitemid 37463243)
24. Caiolfa V. R., Zamai M., Malengo G., et al. Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. J Cell Biol: 2007; 179 5 1067 1082 (Pubitemid 350223499)
25. Deng G., Royle G., Wang S., Crain K., Loskutoff D. J. Structural and functional analysis of the plasminogen activator inhibitor-1 binding motif in the somatomedin B domain of vitronectin. J Biol Chem: 1996; 271 22 12716 12723
26. Kiyan J., Kiyan R., Haller H., Dumler I. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J: 2005; 24 10 1787 1797 (Pubitemid 40769498)
27. Liu D., Aguirre Ghiso J., Estrada Y., Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell: 2002; 1 5 445 457 (Pubitemid 41039125)
28. Eastman B. M., Jo M., Webb D. L., Takimoto S., Gonias S. L. A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen. Cell Signal: 2012; 24 9 1847 1855
29. Jo M., Thomas K. S., O'Donnell D. M., Gonias S. L. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor. J Biol Chem: 2003; 278 3 1642 1646 (Pubitemid 36801395)
30. Guerrero J., Santibañez J. F., González A., Martínez J. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp Cell Res: 2004; 292 1 201 208 (Pubitemid 38058276)
31. D'Alessio S., Gerasi L., Blasi F. uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro. J Cell Sci: 2008; 121 Pt 23 3922 3932
32. Jo M., Thomas K. S., Takimoto S., et al. Urokinase receptor primes cells to proliferate in response to epidermal growth factor. Oncogene: 2007; 26 18 2585 2594 (Pubitemid 46632010)
33. Resnati M., Guttinger M., Valcamonica S., Sidenius N., Blasi F., Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J: 1996; 15 7 1572 1582 (Pubitemid 26112379)
34. Fazioli F., Resnati M., Sidenius N., Higashimoto Y., Appella E., Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J: 1997; 16 24 7279 7286 (Pubitemid 28010488)
35. Ragno P. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol Life Sci: 2006; 63 9 1028 1037 (Pubitemid 43800773)
36. Hoyer-Hansen G., Ploug M., Behrendt N., Ronne E., Dano K. Cell-surface acceleration of urokinase-catalyzed receptor cleavage. Eur J Biochem: 1997; 243 1-2 21 26 (Pubitemid 27060380)
37. Hoyer-Hansen G., Pessara U., Holm A., et al. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. Biochem J: 2001; 358 Pt 3 673 679 (Pubitemid 32896955)
38. Montuori N., Carriero M. V., Salzano S., Rossi G., Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem: 2002; 277 49 46932 46939 (Pubitemid 36159197)
39. Montuori N., Bifulco K., Carriero M. V., et al. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cell Mol Life Sci: 2011; 68 14 2453 2467
40. Selleri C., Montuori N., Ricci P., et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood: 2005; 105 5 2198 2205 (Pubitemid 40731813)
41. Bass R., Ellis V. Regulation of urokinase receptor function and pericellular proteolysis by the integrin alpha(5)beta(1). Thromb Haemost: 2009; 101 5 954 962
42. Madsen C. D., Ferraris G. M., Andolfo A., Cunningham O., Sidenius N. uPAR-induced cell adhesion and migration: vitronectin provides the key. J Cell Biol: 2007; 177 5 927 939 (Pubitemid 46873097)
43. Xue W., Kindzelskii A. L., Todd R. F. III, Petty H. R. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol: 1994; 152 9 4630 4640
44. Bohuslav J., Horejsí V., Hansmann C., et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med: 1995; 181 4 1381 1390
45. Simon D. I., Rao N. K., Xu H., et al. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood: 1996; 88 8 3185 3194 (Pubitemid 26357403)
46. Gyetko M. R., Todd R. F. III, Wilkinson C. C., Sitrin R. G. The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest: 1994; 93 4 1380 1387 (Pubitemid 24116372)
47. Wei Y., Czekay R. P., Robillard L., et al. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding. J Cell Biol: 2005; 168 3 501 511 (Pubitemid 40205071)
48. Wei Y., Tang C. H., Kim Y., et al. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J Biol Chem: 2007; 282 6 3929 3939 (Pubitemid 47084483)
49. Chaurasia P., Aguirre-Ghiso J. A., Liang O. D., Gardsvoll H., Ploug M., Ossowski L. A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. J Biol Chem: 2006; 281 21 14852 14863 (Pubitemid 43855190)
50. Wei Y., Lukashev M., Simon D. I., et al. Regulation of integrin function by the urokinase receptor. Science: 1996; 273 5281 1551 1555 (Pubitemid 26301666)
51. Wei Y., Eble J. A., Wang Z., Kreidberg J. A., Chapman H. A. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell: 2001; 12 10 2975 2986 (Pubitemid 33062955)
52. Zhang F., Tom C. C., Kugler M. C., et al. Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol: 2003; 163 1 177 188 (Pubitemid 37271444)
53. Wei C., Möller C. C., Altintas M. M., et al. Modification of kidney barrier function by the urokinase receptor. Nat Med: 2008; 14 1 55 63
54. Smith H. W., Marra P., Marshall C. J. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. J Cell Biol: 2008; 182 4 777 790
55. Nguyen D. H., Catling A. D., Webb D. J., et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol: 1999; 146 1 149 164 (Pubitemid 29349971)
56. Kjoller L., Hall A. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J Cell Biol: 2001; 152 6 1145 1157 (Pubitemid 34280173)
57. Furlan F., Galbiati C., Jorgensen N. R., et al. Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function. J Bone Miner Res: 2007; 22 9 1387 1396 (Pubitemid 351339683)
58. Edwards S., Lalor P. F., Tuncer C., Adams D. H. Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner. Br J Cancer: 2006; 95 11 1545 1554 (Pubitemid 44863358)
59. Hillig T., Engelholm L. H., Ingvarsen S., et al. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor. J Biol Chem: 2008; 283 22 15217 15223
60. Gårdsvoll H., Kjaergaard M., Jacobsen B., Kriegbaum M. C., Huang M., Ploug M. Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor. J Biol Chem: 2011; 286 50 43515 43526
61. Bifulco K., Longanesi-Cattani I., Franco P., et al. Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion. PLoS ONE: 2012; 7 9 e44806
62. Bershadsky A., Kozlov M., Geiger B. Adhesion-mediated mechanosensitivity: a time to experiment, and a time to theorize. Curr Opin Cell Biol: 2006; 18 5 472 481 (Pubitemid 44332917)
63. Ciambrone G. J., McKeown-Longo P. J. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells. J Biol Chem: 1992; 267 19 13617 13622
64. Wilcox S. A., Reho T., Higgins P. J., Tominna-Sebald E., McKeown-Longo P. J. Localization of urokinase to focal adhesions by human fibrosarcoma cells synthesizing recombinant vitronectin. Biochem Cell Biol: 1996; 74 6 899 910 (Pubitemid 126733750)
65. Salasznyk R. M., Zappala M., Zheng M., Yu L., Wilkins-Port C., McKeown-Longo P. J. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Matrix Biol: 2007; 26 5 359 370 (Pubitemid 46803257)
66. Hoyer-Hansen G., Ronne E., Solberg H., et al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem: 1992; 267 25 18224 18229
67. Koolwijk P., Sidenius N., Peters E., et al. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood: 2001; 97 10 3123 3131
68. Andolfo A., English W. R., Resnati M., Murphy G., Blasi F., Sidenius N. Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. Thromb Haemost: 2002; 88 2 298 306 (Pubitemid 34873713)
69. Hoyer-Hansen G., Ploug M., Behrendt N., Ronne E., Dano K. Cell-surface acceleration of urokinase-catalyzed receptor cleavage. Eur J Biochem: 1997; 243 1-2 21 26 (Pubitemid 27060380)
70. Hoyer-Hansen G., Ronne E., Solberg H., et al. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem: 1992; 267 25 18224 18229
71. Margheri F., Manetti M., Serratì S., et al. Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells. Arthritis Rheum: 2006; 54 12 3926 3938 (Pubitemid 44955896)
72. Montuori N., Cosimato V., Rinaldi L., Rea V. E., Alfano D., Ragno P. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors. Thromb Haemost: 2012; 109 2 109
73. Degryse B., Resnati M., Czekay R. P., Loskutoff D. J., Blasi F. Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J Biol Chem: 2005; 280 26 24792 24803 (Pubitemid 40934570)
74. Simon D. I., Wei Y., Zhang L., et al. Identification of a urokinase receptor-integrin interaction site. Promiscuous regulator of integrin function. J Biol Chem: 2000; 275 14 10228 10234 (Pubitemid 30202079)
75. Tarui T., Andronicos N., Czekay R. P., et al. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling. J Biol Chem: 2003; 278 32 29863 29872 (Pubitemid 36962374)
76. Huai Q., Zhou A., Lin L., et al. Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes. Nat Struct Mol Biol: 2008; 15 4 422 423 (Pubitemid 351483393)
77. Hoyer-Hansen G., Behrendt N., Ploug M., Dano K., Preissner K. T. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction. FEBS Lett: 1997; 420 1 79 85 (Pubitemid 28037204)
78. Sidenius N., Blasi F. Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin. FEBS Lett: 2000; 470 1 40 46 (Pubitemid 30155620)
79. Chain D., Kreizman T., Shapira H., Shaltiel S. Plasmin cleavage of vitronectin. Identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1. FEBS Lett: 1991; 285 2 251 256